ストックスクリーナーアプリを入手
45.11
0.36%
0.16
前日終値:
$44.95
開ける：
$44.55
24時間の取引高:
1.31M
Relative Volume:
0.66
時価総額：
$2.42B
収益：
-
当期純損益:
$-38.99M
株価収益率:
-15.05
EPS:
-2.9966
ネットキャッシュフロー:
$-24.94M
1週間 パフォーマンス:
-8.72%
1か月 パフォーマンス:
-32.80%
6か月 パフォーマンス:
-38.46%
1年 パフォーマンス:
-17.43%
1日の値動き範囲:
$44.20
$46.97
1週間の範囲:
$44.20
$49.46
52週間の値動き範囲:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
名前
Soleno Therapeutics Inc
セクター
電話
650-213-8444
住所
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
SLNO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
45.11 | 2.41B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | 開始されました | Wolfe Research | Outperform |
| 2025-10-07 | 開始されました | Goldman | Buy |
| 2025-08-20 | 開始されました | Wells Fargo | Overweight |
| 2025-06-23 | 開始されました | TD Cowen | Buy |
| 2025-03-05 | 再開されました | Stifel | Buy |
| 2024-12-02 | 繰り返されました | Robert W. Baird | Outperform |
| 2024-12-02 | 繰り返されました | Stifel | Buy |
| 2024-09-03 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-10 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-05 | 開始されました | Piper Sandler | Overweight |
| 2024-01-23 | 開始されました | Stifel | Buy |
| 2023-11-21 | 再開されました | Guggenheim | Buy |
| 2020-09-29 | 開始されました | Guggenheim | Buy |
| 2020-01-10 | 開始されました | Craig Hallum | Buy |
| 2019-12-23 | 開始されました | Oppenheimer | Outperform |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Soleno Therapeutics Inc (SLNO) 最新ニュース
Does Soleno Therapeutics Inc. (6XC) stock trade below intrinsic valueQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Wolfe Research Initiates Soleno Therapeutics (SLNO) Coverage with Outperform Rating, $75 PT, Dismisses Patient Slowdown Concerns - Insider Monkey
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - PR Newswire
Will Soleno Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com
Why Soleno Therapeutics Inc. (6XC) stock is a strong analyst pickBond Market & Consistent Profit Trade Alerts - newser.com
Is Soleno Therapeutics Inc. stock trading near support levelsQuarterly Market Review & Step-by-Step Trade Execution Guides - newser.com
How analysts revise price targets for Soleno Therapeutics Inc. (6XC) stock2025 Key Highlights & Smart Swing Trading Alerts - newser.com
Will Soleno Therapeutics Inc. stock benefit from upcoming earnings reportsTrend Reversal & Safe Investment Capital Preservation Plans - newser.com
Will Soleno Therapeutics Inc. (6XC) stock attract long term capital inflows2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Can Soleno Therapeutics Inc. stock outperform in 2025 bull market - newser.com
(SLNO) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Published on: 2025-11-19 15:57:35 - newser.com
Is Soleno Therapeutics Inc. stock a bargain at current levels - newser.com
Analyzing net buyer seller activity in Soleno Therapeutics Inc.Earnings Performance Report & Accurate Buy Signal Notifications - newser.com
Real time social sentiment graph for Soleno Therapeutics Inc.July 2025 Volume & Smart Allocation Stock Reports - newser.com
Strategies to average down on Soleno Therapeutics Inc.Portfolio Return Report & Accurate Buy Signal Notifications - newser.com
Published on: 2025-11-19 04:05:29 - newser.com
Full technical analysis of Soleno Therapeutics Inc. stockQuarterly Market Review & Fast Gaining Stock Reports - newser.com
Wolfe Research Initiates Coverage of Soleno Therapeutics (SLNO) with Outperform Recommendation - Nasdaq
Soleno Therapeutics Inc. (SLNO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire
Commit To Buy Soleno Therapeutics At $30, Earn 20.1% Annualized Using Options - Nasdaq
Wolfe Research initiates Soleno Therapeutics stock with Outperform rating By Investing.com - Investing.com Nigeria
Wolfe Research initiates Soleno Therapeutics stock with Outperform rating - Investing.com India
Soleno Therapeutics Inc (SLNO) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):